Insiders UroGen Pharma Ltd.

Equities

URGN

IL0011407140

Real-time Estimate Cboe BZX Other stock markets 11:48:34 2024-04-30 am EDT			5-day change	1st Jan Change
13.91 ^USD	-0.93%		-4.34%	-7.33%

Apr. 15	UroGen Pharma Says FDA Accepts Investigational New Drug Application for Potential Bladder Cancer Treatment	MT
Apr. 03	UroGen Pharma Sues Teva Pharmaceuticals Over Alleged Patent Infringement of Jelmyto	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UroGen Pharma Ltd. Announces the Appointment of James Robinson to Its Board of Directors	23-07-25	CI
Urogen Pharma Ltd. Appoints Dan Wildman to the Board of Directors	22-11-09	CI
Urogen Pharma Ltd. Appoints Dr. Leana S. Wen to the Board of Directors and Audit Committee	22-09-12	CI
Phathom Pharmaceuticals Names Molly Henderson Finance, Business Chief	22-03-22	MT
Insider Sell: Urogen Pharma	22-01-07	MT
UroGen Pharma Announces Board Appointments	20-09-09	CI
UroGen Pharma Appoints Molly Henderson as Chief Financial Officer, Effective October 1, 2020	20-09-09	CI
Urogen Pharma Ltd. Announces Executive Promotions	20-03-23	CI
UroGen Pharma Ltd. Announces Executive Changes	19-01-03	CI
Jones “Woody” Bryan Joins UroGen Pharma Ltd. as Senior Vice President of Business Development	18-09-11	CI
UroGen Pharma Ltd. Announces Resignation of Gil Hakim, President, Israel Operations	18-08-30	CI
UroGen Pharma Ltd. Appoints Peter P. Pfreundschuh as Chief Financial Officer, Effective August 20, 2018	18-08-08	CI
Urogen Pharma Appoints Shawn Cline Tomasello to its Board of Directors	18-07-10	CI
UroGen Pharma Ltd Announces Executive Changes	18-06-05	CI
UroGen Pharma Ltd. Appoints Stephen Mullennix as Chief Operating Officer	18-02-14	CI
Urogen Pharma Ltd. Announces Executive Appointments	18-01-08	CI
Urogen Pharma Ltd. Announces Executive Appointments	17-12-12	CI
UroGen Pharma Ltd. Appoints Cynthia Butitta as Director	17-11-02	CI
UroGen Pharma Ltd. Appoints Jeffrey Bova as Vice President of Commercial and James Ottinger as Vice President of Regulatory Affairs	17-10-26	CI
Urogen Pharma Ltd. Appoints Paul Chu as Vice President of Business Development	17-09-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders UroGen Pharma Ltd.

Equities

URGN

IL0011407140

Insiders

Filters